Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹563 Cr₹475 Cr₹29 Cr₹-251 Cr₹-119 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹563 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹563 Cr
Mar2025₹475 Cr
Mar2024₹29 Cr
Mar2023₹-251 Cr
Mar2022₹-119 Cr

How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹563 Cr
18.65
Mar2025 ₹475 Cr
1,523.94
Mar2024 ₹29 Cr
Positive
Mar2023 ₹-251 Cr
Negative
Mar2022 ₹-119 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,902.2 Cr 0.7% -7.4% -2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,122.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹266,424.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,914.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹114,599.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,112.0 Cr 3.2% 5% -11.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.7%

-7.4%

-2.6%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses